RecruitingNot ApplicableNCT06171269

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

A Prospective Study of Lower Dose Radiation (LO-RADS) for Prostate Cancer Using MRI Dose Mapping to Preserve Quality of Life


Sponsor

University of Chicago

Enrollment

60 participants

Start Date

Jan 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to gather information on the safety and effectiveness of using an imaging technique called magnetic resonance imaging (MRI) to decrease radiation dose to the uninvolved prostate (areas of the prostate that do not clearly have cancer cells) while increasing radiation dose to the nodules (hardened areas of the prostate that have cancer cells).


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using specialized MRI scans to map where prostate cancer is most concentrated, so doctors can deliver higher radiation doses to those areas while reducing radiation to healthy tissue — with the goal of improving cancer control while preserving sexual and urinary function. **You may be eligible if...** - You are an adult male (18 or older) - You have been diagnosed with intermediate or high-risk prostate cancer (confined to the pelvis) confirmed by biopsy, and the tumor is visible on MRI - You have not had any prior treatment for prostate cancer (though being on active surveillance without treatment is acceptable) - You are generally in good health for radiation treatment **You may NOT be eligible if...** - Your cancer has spread beyond the pelvis (distant metastases) - You have had prior pelvic radiation or brachytherapy - You have another active cancer (except localized skin cancers) - You cannot have an MRI (e.g., due to metallic implants, severe claustrophobia, or poor kidney function that prevents contrast use) - You are having a spacer (hydrogel or hyaluronic acid) placed between the prostate and rectum Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation

Radiation to the prostate gland will be given daily (Mon-Friday) for 4 weeks.

RADIATIONMRI

The study doctor will use an MRI scan to take pictures of the prostate gland. These images of the prostate gland will let the study doctor know which areas of the prostate contain cancer cells that need to be targeted with higher doses of radiation and which uninvolved areas to target with lower doses of radiation.

OTHERAndrogen Deprivation Therapy

Treatment of treating physician choice will be given for 6-24 months.


Locations(1)

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06171269


Related Trials